Search Results
Results for: VALEANT PHARMACEUTICALS INTERNATIONAL INC (Save this search)
Number of Results: 114
Actavis nears USD64bn deal with Allergan - report
17 November 2014 - Ireland-based pharmaceutical major Actavis Plc (NYSE:ACT) is close to taking over US peer Allergan Inc (NYSE:AGN) in a cash-and-stock deal that could value the c...

Nicox sheds US diagnostoc unit to Valeant Pharmaceuticals
17 November 2014 - French biopharmaceutical company Nicox SA (EPA:COX) has announced the sale of its US diagnostic unit Nicox Inc to Canada-based speciality drug maker Valeant Phar...

VALEANT WRAPS UP DEAL WITH NESTLE
Canadian drugmaker Valeant Pharmaceuticals International Inc (TSE:VRX; NYSE:VRX) said it had completed the USD1.4bn (EUR1bn) cash sale of its filler and toxin assets to Swiss Nestl...

Valeant may further sweeten bid for Allergan
27 October 2014 – Canadian drug maker Valeant Pharmaceuticals International Inc (TSE:VRX) said today it was willing to further improve its cash-and-stock bid for US sector pl...

VALEANT FINALISES TAKEOVER OF US PRECISION DERMATOLOGY
Canada's Valeant Pharmaceuticals International Inc (TSE:VRX) said it had closed its acquisition of US-based dermatology products company PreCision Dermatology Inc....

AKORN SELLS ECR PHARMACEUTICALS TO VALEANT
US niche pharmaceuticals company Akorn Inc (NASDAQ:AKRX) said it had sold its unit ECR Pharmaceuticals Co Inc to Canadian drug maker Valeant Pharmaceuticals International Inc (TSE:...

Valeant extends tender bid for Allergan to 31 Dec
18 August 2014 - Canadian drugmaker Valeant Pharmaceuticals International Inc (TSE:VRX) said it had extended to 31 December its cash-and-stock bid for US botox producer Allergan In...

FTC asks for more info on Valeant, Allergan deal
12 August 2014 – Canadian drugmaker Valeant Pharmaceuticals International Inc (TSE:VRX) has received a second request for additional information under the Hart-Scott-Rodino (...

VALEANT AGREES USD1.4BN SALE OF FILLER, TOXIN ASSETS TO NESTLE
Canadian drugmaker Valeant Pharmaceuticals International Inc (TSE:VRX; NYSE:VRX) said it would shed its filler and toxin assets to Swiss Nestle SA (VTX:NESN) in a USD1.4bn (EUR1bn)...

You can compare news articles by clicking on the tick buttons
1   2   3   4   5   6   7   8   9   10   11   12   >